用户48783635432019-04-09 14:29
【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文
艾萨克的猫2018-10-23 23:00
$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文
$Navidea Biopharmaceuticals, Inc.(NAVB)$ DEF 14A - Other definitive proxy statements Filed: 2018-07-09 AccNo: 0001437749-18-013138 Size: 1 MB 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ PRE 14A - Other preliminary proxy statements Filed: 2018-06-07 AccNo: 0001437749-18-011441 Size: 1 MB 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ SD - Filed: 2018-05-31 AccNo: 0001437749-18-010994 Size: 16 KB 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-09 AccNo: 0001437749-18-009223 Size: 6 MB 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-05-08 AccNo: 0001437749-18-009054 Size: 145 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-04-04 AccNo: 0001437749-18-006324 Size: 25 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other Events 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-04-02 AccNo: 0001437749-18-006076 Size: 21 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ...
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-15 AccNo: 0001437749-18-004756 Size: 14 MB 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-03-08 AccNo: 0001437749-18-004218 Size: 223 KBItem 2.02: Results of Operations and Financial ConditionItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain...
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-02-23 AccNo: 0001437749-18-003184 Size: 20 KBItem 8.01: Other Events 网页链接